Scientists found a hidden reserve of blood stem cells that sleep for months in mice and may keep blood and immunity going for life. Here’s what it could mean.
Blood Stem Cells Have a Hidden ‘Deep Sleep’ Reserve, Mouse Study Finds Read More »
Japan begins first approved stem cell therapy for Parkinson’s using iPS cells. What the early trial showed, how it works, and what it means for patients.
The Marcus Foundation has committed $28.7 million to USC research advancing a stem-cell-derived heart therapy toward a planned 2027 clinical trial.
A new Nature Communications study shows bovine embryonic stem cells can self-organize into 3D tissues containing muscle, endothelial cells, and neurons. Here is what it means for cultivated beef research.
February 2026 marked a remarkable month for stem cell research, with several groundbreaking studies and announcements pushing the boundaries of regenerative medicine. From in-utero treatments for birth defects to potential game-changers in aging and cancer, these developments highlight the accelerating translation of stem cell science into real-world clinical impact. A Milestone in Fetal Medicine: World-First
Cannabidiol Enhances SIRT1 and Autophagy for the Maintenance of Human Mesenchymal Stem Cells, published in the journal In Vivo, investigated if low-dose cannabidiol (CBD) can significantly delay cellular aging in human mesenchymal stem cells (MSCs), offering potential improvements for regenerative medicine applications. Also accessible via the National Institutes of Health (NIH) and reported on by
Peer-reviewed study shows CBD delays cellular aging in mesenchymal stem cells Read More »
The top 10 headlines that defined stem cell research in 2025, based on major scientific announcements and public engagement.
Top 10 Stem Cell Highlights and Breakthroughs of 2025 Read More »
